Why the study?
Treatment of elderly patients with coronary artery disease and atrioventricular block remains debatable, with no clear recommendations regarding the sequence of surgical interventions.
Does epicardial lead placement during surgical revascularization improve outcomes and reduce complications in elderly patients with multivessel coronary artery disease and complete atrioventricular block?
Does epicardial lead placement during surgical revascularization improve outcomes and reduce complications in elderly patients with multivessel coronary artery disease and complete atrioventricular block?
Epicardial lead placement during surgical revascularization may be a safe and socio-economically beneficial approach for elderly patients with coronary artery disease and complete atrioventricular block, avoiding complications associated with dual antiplatelet therapy during subsequent implantation.
Answers are grounded in this paper and cite their sources.
May support epicardial leads during revascularization to lower rehospitalizations in elderly CAD patients with AV block; hypothesis-generating and requires prospective trials.
Complete atrioventricular block is a dangerous complication in elderly patients with coronary artery disease that requires surgical treatment. Treatment of elderly patients with coronary artery disease and atrioventricular block is a debatable problem, and at the moment, there are no clear recommendations regarding the sequence of surgical interventions in this age group. In our opinion, in some cases it is advisable to perform epicardial lead placement during revascularization, because the risk of complications during the implantation procedure increases on the background of dual antiplatelet therapy, which is required after coronary artery bypass grafting. In addition, this approach provides a significant socio-economic effect, saving a patient from re-hospitalization and intervention for conduction disorders. This article presents a clinical observation with a step-by-step algorithm of actions in multivessel coronary artery disease with complete symptomatic atrioventricular block.
No takes yet. Share an insight, caveat, or question.
O.O. Zhurba (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: